Ana Foster – PharmaMedic

What’s trending in regulatory affairs? PharmaMedic in discussion with Dr Zubair Hussain

Last year, our colleague Dr Zubair Hussain, Chairman of LE4D Global Regulatory and a PharmaMedic partner, provided an insightful strategic update on critical regulatory trends at PharmaMedic's inaugural virtual breakfast briefing. In this new article, we sat down with Dr Hussain once again to learn his latest insights on the three key issues he tips for the top of the regulatory agenda over the coming months. Read on to find out more.

7 Jun 2022

Join Our Free Webinar: Beyond the Numbers… Strategic Partnering with your Statistical Colleagues

PharmaMedic is delighted to announce our next virtual event on Wednesday 29th June 2022 at 8 am (GMT). In this briefing, we will be discussing the integral role that statisticians, and innovative statistical approaches play in enabling medical, clinical, and commercial teams to make better development decisions, conduct more efficient research, and ensure more successful commercialisation. We are delighted to welcome as speakers two seasoned statistical leaders, Nelson Kinnersley, Founder and Director at Octa Consulting Services Ltd, and Alexander Schacht, Executive VP Launch and Commercialisation Data Science at Veramed. Read on to learn more, and to register your attendance.

1 Jun 2022

Takeaways from our April joint webinar- Medical Affairs 3.0: A Discipline Comes of Age

We enjoyed our first joint webinar with PharmaMedic and Triducive of 2022. Our guest speakers, Dr Malcolm Barratt-Johnson (PharmaMedic) and Tim Warren (Triducive) joined Nick Williams (Triducive) for a discussion and interactive Q&A on the evolving and increasingly strategic role of medical affairs within pharma and life sciences businesses. Read on for the key takeaways.

3 May 2022

Living with COVID- the role of antivirals

In the UK, we now seem to be moving into a new phase of pandemic management, with the government aiming to” transition to managing COVID-19 like other respiratory illnesses”. In their recent March 2022 statement, the government attributes this evolution in approach to vaccines and treatments. In this short article, we overview the current role of antivirals and monoclonal antibodies and look ahead to future developments in our attempt to manage the day-to day risks of living with COVID-19.

5 Apr 2022

Join Our Free Webinar: Medical Affairs 3.0: A Discipline Comes of Age – Focus on evidence generation & dissemination for strategic impact

Join Triducive and PharmaMedic for an interactive webinar on Thursday 28th April at 8.00AM. Keynote speakers Dr Malcolm Barratt-Johnson and Tim Warren will be discussing the strategic role of medical affairs in Pharma and the potential role of Delphi based studies for strategic impact. Find out more.

29 Mar 2022

The value of a pharmaceutical physician as a Non-Executive Director

Non-Executive Directors play an integral role for any organisation, not least within the life science space where leadership often needs to draw on a broad range of strategic and tactical expertise to drive the business forward. In this short Q&A article, we interview PharmaMedic Managing Director Dr Malcolm Barratt-Johnson about the value that a pharmaceutical physician delivers in the role of NED.

22 Mar 2022

Breakfast Briefing Takeaways: Medical affairs in 2022: Business as usual, or a reshaped environment

We enjoyed our first virtual breakfast briefing of 2022, with a new lively panel discussion format. Our guest panelists, Dr Lucy Cook (PharmaMedic consultant and Director of Wiltshire Pharma), Mr Guy Francis (UK Marketing Director, Amarin UK) and Mr Andy Wise (Managing Pharma Consultant, Blue Pelican) joined Dr Malcolm Barratt-Johnson to discuss key themes set to shape medical affairs in 2022. Read on for a summary of key takeaways and to access our recording of the event.

1 Mar 2022

How JP Morgan Healthcare trends inform pharma ‘mood music’ for 2022

The JP Morgan Healthcare conference is the flagship global investment focused event and marked its 40th year in January 2022 with a virtual event. Typically, the hot topics from JP Morgan set the tone for the life science community for the rest of the year. In this short round up, we will summarise some of the key themes and ‘mood music’ emerging from the conference that have been reported by the industry press.

15 Feb 2022

Join our Virtual Breakfast Briefing: Medical Affairs in 2022: Business as usual, or a reshaped environment?

PharmaMedic is delighted to announce our next virtual breakfast briefing on Thursday 24th February 2022 at 8 am. For this virtual session, we invite you to join experts Dr Malcolm Barratt-Johnson, Mr Guy Francis, Dr Lucy Cook and Mr Andrew Wise for a lively panel discussion tackling the key industry and medical affairs trends we expect to emerge in 2022 and how we can best adapt to succeed. Learn more about the agenda and register here.

2 Feb 2022

Targeted approaches to development and commercialisation- trends for 2022

Over the last two years, as a whole society and within the pharmaceutical community specifically, we have been forced to adapt and change at an unprecedented scale and speed. While we certainly hope that 2022 will represent less disruption and more recovery, we expect a continued climate of change. In this article Dr Malcolm Barratt-Johnson outlines some of the key trends set to shape the industry in 2022.

31 Jan 2022